Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

Eclipta alba L. (Urang-Aring) can help treat hair loss.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Natural products show promise for treating diseases but need more research to understand and use them effectively.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

New compounds may help treat prostate issues without affecting androgen receptors.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

New steroids were effective in blocking male hormone receptors in hamster prostates.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Finasteride potentially treats hair loss by reducing DHT production.

New compounds may soon be tested to treat excessive hair growth in women.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.